MedTrace Logo

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

NCT00698126 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4099

Last updated 2016-10-28

No results posted yet for this study

Summary

This trial is conducted in Europe. The aim of this observational study is to evaluate the incidence of major hypoglycaemic episodes in patients with type 2 diabetes treated with NovoRapid® or Soluble Human Insulin under normal clinical practice conditions.

Conditions

Interventions

DRUG

soluble human insulin

Observational study; use of the products as in the normal clinical practice conditions

DRUG

biphasic insulin aspart

Observational study; use of the products as in the normal clinical practice conditions

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00698126 on ClinicalTrials.gov